Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
In the proposed study, the investigators plan to evaluate the efficacy and safety of
Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for the treatment of respiratory
and urinary tract acute bacterial infection.